Healthy Mediation Adherence To Transform and Effectively Relieve Symptoms

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 15, 2021

Primary Completion Date

May 26, 2021

Study Completion Date

May 26, 2021

Conditions
COPDDiabetesHypertension
Interventions
BEHAVIORAL

Supportive counseling

"Participants in the control arm will receive 3 placebo sessions to control for the potentially confounding effect of personalized attention from the care coach on the relationship between the intervention and outcomes. The interventionist will review a patient education booklet for COPD self-management over the 3 sessions and address any question raised by the study subject."

BEHAVIORAL

Education on SMB

Goal is to educate patient on SMB based on responses during 15-month interview and screener call, and assess patient's motivation for change.

BEHAVIORAL

Psychoeducation on ATs for maladaptive beliefs (if applicable)

Goal is to educate patient on relationship between thoughts and SMB, and identify maladaptive beliefs, automatic thoughts, and cognitive distortions.

BEHAVIORAL

Psychoeducation on emotional response (if applicable)

Goal is to educate patient on relationship between emotions and COPD + SMB, identify

Trial Locations (2)

10029

Icahn School of Medicine at Mount Sinai, New York

60208

Northwestern University, Chicago

All Listed Sponsors
collaborator

Northwestern University

OTHER

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT04656093 - Healthy Mediation Adherence To Transform and Effectively Relieve Symptoms | Biotech Hunter | Biotech Hunter